Amlodipine Besylate
- Product NDC
- 0615-7942
- 11-digit product format
- 006157942
- Labeler code
- 0615
- Product ID
- 0615-7942_b1704f51-8080-4f2d-8ef8-1e01464b783c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amlodipine Besylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA077073
- Marketing category
- ANDA
- Marketing start
- 2007-09-26
- Marketing end
- 0000-00-00
- Substance
- AMLODIPINE BESYLATE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-7942-05 | 2021-03-05 | C162847 | 48780-1 | 9d75b9d0-5e3c-f424-e053-dadaa90a57ce | aaa72b1e-5276-4dc7-991f-368e91b2bb34 |
| 0615-7942-30 | 2021-03-05 | C162847 | 48780-1 | 9d75b9d0-5e3c-f424-e053-dadaa90a57ce | aaa72b1e-5276-4dc7-991f-368e91b2bb34 |
| 0615-7942-39 | 2021-03-05 | C162847 | 48780-1 | 9d75b9d0-5e3c-f424-e053-dadaa90a57ce | aaa72b1e-5276-4dc7-991f-368e91b2bb34 |
| 0615-7942-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-5e3c-f424-e053-dadaa90a57ce | aaa72b1e-5276-4dc7-991f-368e91b2bb34 |
| 0615-7942-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-5e3c-f424-e053-dadaa90a57ce | aaa72b1e-5276-4dc7-991f-368e91b2bb34 |
| 0615-7942-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-5e3c-f424-e053-dadaa90a57ce | aaa72b1e-5276-4dc7-991f-368e91b2bb34 |